Srisopa Ruangnoo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Srisopa Ruangnoo has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Arunporn Itharat
Department of Applied Thai Traditional Medicine, Faculty of Medicine, Thammasat University, Klongluang, Pathumthani 12120, Thailand
2 shared publications Arunporn Itharat
Department of Applied Thai Traditional Medicine, Faculty of Medicine, Thammasat University
1 shared publicationJanjira Inprasit
Student of Doctor of Philosophy Program in Applied Thai Traditional Medicine, Faculty of Medicine, Thammasat University
1 shared publication- Kanokwan Sangmukdee
Department of Agricultural Technology, Faculty of Science and Technology, Thammasat University, Pathum Thani 12120, Thailand
1 shared publication - Kornkanok Chamchusri
Department of Agricultural Technology, Faculty of Science and Technology, Thammasat University, Pathum Thani 12120, Thailand
1 shared publication Neal M Davies
Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta
1 shared publication
Latest Publications
- Open Access
- 31 August 2024
- Published by AMJAMDC, Thammasat University in Asian Medical Journal and Alternative Medicine
- Vol. 24 (2) , 33-44
Quality Control and Evaluation of Anti-inflammatory and Antioxidant Activities of Ethanolic Extracts from Ha-Rak remedy, Piper betle Linn., Garcinia mangostana Linn., and Their Combined Remedies
Introduction: A Thai herbal remedy, Ha-Rak (HR), Piper betle Linn. (PB) leaves, and Garcinia mangostana Linn. (GM) pericarps tend to relieve inflammatory related atopic dermatitis (AD). Additionally, antioxidants have important role in the AD prevention. Objectives: To develop combined formulas of HR, PB and GM extracts and investigate them on anti-inflammatory and antioxidant activities, the total flavonoid content (TFC) and the total phenolic content (TPC). Methods: The quality of each dried plant material was evaluated according to Thai Herbal Pharmacopoeia (THP) criteria. Each was extracted by maceration with 95% ethanol, and then combined with a remedy. The inflammatory properties of each extract were assessed using the production inhibition of TNF- α from RAW 264.7 cells. The antioxidant properties were assessed using DPPH and ABTS radical scavenging. The TFC and TPC were also analyzed. Results: The quality of all plant materials passed Thai herbal pharmacopeia standards. HR showed the highest anti inflammatory activity. The combination HMB-321, which is composed of HR:GM:PB in a ratio of 3:2:1, showed the highest anti-inflammatory activity among other combined formulas. Moreover, HMB-321 showed moderate antioxidant activities and capacities. PB showed the highest antioxidant activity but less anti-inflammatory activity. HMB-123, whose proportion of HR:GM:PB was 1:2:3, showed the highest antioxidant activity among the combination of extracts but showed less anti-inflammatory activity. Conclusions: The combination HMB-321 could be a candidate remedy for the prevention and treatment of AD. Further study should be directed to in vivo testing and clinical trials for anti-inflammatory and antioxidant activities.
- 31 August 2024
- Published by AMJAMDC, Thammasat University in Asian Medical Journal and Alternative Medicine
- Vol. 24 (2) , 33-44
Open AccessQuality Control and Evaluation of Anti-inflammatory and Antioxidant Activities of Ethanolic Extracts from Ha-Rak remedy, Piper betle Linn., Garcinia mangostana Linn., and Their Combined Remedies
Introduction: A Thai herbal remedy, Ha-Rak (HR), Piper betle Linn. (PB) leaves, and Garcinia mangostana Linn. (GM) pericarps tend to relieve inflammatory related atopic dermatitis (AD). Additionally, antioxidants have important role in the AD prevention. Objectives: To develop combined formulas of HR, PB and GM extracts and investigate them on anti-inflammatory and antioxidant activities, the total flavonoid content (TFC) and the total phenolic content (TPC). Methods: The quality of each dried plant material was evaluated according to Thai Herbal Pharmacopoeia (THP) criteria. Each was extracted by maceration with 95% ethanol, and then combined with a remedy. The inflammatory properties of each extract were assessed using the production inhibition of TNF- α from RAW 264.7 cells. The antioxidant properties were assessed using DPPH and ABTS radical scavenging. The TFC and TPC were also analyzed. Results: The quality of all plant materials passed Thai herbal pharmacopeia standards. HR showed the highest anti inflammatory activity. The combination HMB-321, which is composed of HR:GM:PB in a ratio of 3:2:1, showed the highest anti-inflammatory activity among other combined formulas. Moreover, HMB-321 showed moderate antioxidant activities and capacities. PB showed the highest antioxidant activity but less anti-inflammatory activity. HMB-123, whose proportion of HR:GM:PB was 1:2:3, showed the highest antioxidant activity among the combination of extracts but showed less anti-inflammatory activity. Conclusions: The combination HMB-321 could be a candidate remedy for the prevention and treatment of AD. Further study should be directed to in vivo testing and clinical trials for anti-inflammatory and antioxidant activities.
- Open Access
Enhancement of Plumbagin Production through Elicitation in In Vitro-Regenerated Shoots of Plumbago indica L.
Plumbago indica L. contains a valuable bioactive compound called plumbagin. Elicited regenerated shoots grown in vitro could be another source of high-yielding plumbagin. The purpose of this investigation was to examine the effects of elicitor type and concentration, as well as elicitation period, on plumbagin content in in vitro-regenerated shoots of P. indica. Nodal explants were cultured on Murashige and Skoog (MS) medium containing 1 mg/L benzyladenine (BA) in combination with 0–150 mg/L yeast extract or 50–150 µM salicylic acid for four weeks. Plumbagin levels of 3.88 ± 0.38% and 3.81 ± 0.37% w/w g dry extract were achieved from the 50 and 100 mg/L yeast extract-elicited shoots, which were higher than the value obtained for the control. However, the addition of salicylic acid did not increase the plumbagin content. In the elicitation period experiment, nodal explants were cultured on MS medium supplemented with 1 mg/L BA and 50 mg/L yeast extract for durations of three, four and five weeks. The 4-week yeast extract-elicited shoot had a maximum plumbagin content of 3.22 ± 0.12% w/w g dry extract, greater than that of the control. In summary, the plumbagin content of the in vitro P. indica shoots was enhanced by 4-week elicitation using 50 mg/L yeast extract.
Open AccessEnhancement of Plumbagin Production through Elicitation in In Vitro-Regenerated Shoots of Plumbago indica L.
Plumbago indica L. contains a valuable bioactive compound called plumbagin. Elicited regenerated shoots grown in vitro could be another source of high-yielding plumbagin. The purpose of this investigation was to examine the effects of elicitor type and concentration, as well as elicitation period, on plumbagin content in in vitro-regenerated shoots of P. indica. Nodal explants were cultured on Murashige and Skoog (MS) medium containing 1 mg/L benzyladenine (BA) in combination with 0–150 mg/L yeast extract or 50–150 µM salicylic acid for four weeks. Plumbagin levels of 3.88 ± 0.38% and 3.81 ± 0.37% w/w g dry extract were achieved from the 50 and 100 mg/L yeast extract-elicited shoots, which were higher than the value obtained for the control. However, the addition of salicylic acid did not increase the plumbagin content. In the elicitation period experiment, nodal explants were cultured on MS medium supplemented with 1 mg/L BA and 50 mg/L yeast extract for durations of three, four and five weeks. The 4-week yeast extract-elicited shoot had a maximum plumbagin content of 3.22 ± 0.12% w/w g dry extract, greater than that of the control. In summary, the plumbagin content of the in vitro P. indica shoots was enhanced by 4-week elicitation using 50 mg/L yeast extract.
- Open Access
- 1 January 2024
- Published by Wiley in Advances in Pharmacological and Pharmaceutical Sciences
- Vol. 2024 (1) , 4297596
Chemical and Biological Changes Under Force Degradation and Acceleration Condition of the Combination of Ha‐Rak Remedy, Piper betle, and Garcinia mangostana Extracts for Atopic Dermatitis
Herbal medicine could be an option for atopic dermatitis (AD) treatment for those suffering from global public health. HMB is a new combination of three herb extracts, consisting of the Ha‐Rak (HR) remedy extract, Piper betle (PB) extract, and Garcinia mangostana (GM) extract in equal proportions, using Thai traditional medicine theory, that uses a combination of medications that can improve therapeutic efficacy and reduce side effects and toxicity. HMB extract has anti‐inflammatory and antiallergic properties, is a component for AD treatment, and tends to develop topical products. Drug registration requires stability data. Results from drug stability testing affect not only the efficacy of the drug but also its safety. The aim of this study was to investigate stability through forced degradation and an accelerated study of extracts. Chemical content analysis and in vitro biological activities such as anti‐inflammatory and antiallergic activities determined the effects of all examined samples. Anti‐inflammatory and antiallergic effects were assessed by inhibiting nitric oxide synthesis in RAW 264.7 cells and β‐hexosaminidase release in RBL‐2H3 cells, respectively. High‐performance liquid chromatography (HPLC) assessed content indicators. Moisture and temperature hydrolysis had no significant differences in the chemical or biological properties of the HMB. However, the HMB demonstrated sensitivity to alkaline hydrolysis, showed low anti‐inflammatory activity, and decreased hydroxychavicol, eugenol, and α‐mangostin contents. The contents of the three compounds also decrease with acid hydrolysis. For the accelerated study, anti‐inflammatory and antiallergic effects and hydroxychavicol amount were not significantly different after 180 days at 40°C and 75% RH. Therefore, the contents of eugenol and α‐mangostin were changed. Eugenol in HMB decreased significantly from the 15th day until the 180th day of storage. In addition, α‐mangostin amounts in HMB decreased slightly on 180th day. Fortunately, reducing the two chemicals did not affect anti‐inflammatory or antiallergic effects. For stability, combination extract should be stored in a closed container in the refrigerator at a low temperature and protected from light, high temperature, oxygen, and pH. Further HMB development should avoid pH or oxidation processes or components.
- 1 January 2024
- Published by Wiley in Advances in Pharmacological and Pharmaceutical Sciences
- Vol. 2024 (1) , 4297596
Open AccessChemical and Biological Changes Under Force Degradation and Acceleration Condition of the Combination of Ha‐Rak Remedy, Piper betle, and Garcinia mangostana Extracts for Atopic Dermatitis
Herbal medicine could be an option for atopic dermatitis (AD) treatment for those suffering from global public health. HMB is a new combination of three herb extracts, consisting of the Ha‐Rak (HR) remedy extract, Piper betle (PB) extract, and Garcinia mangostana (GM) extract in equal proportions, using Thai traditional medicine theory, that uses a combination of medications that can improve therapeutic efficacy and reduce side effects and toxicity. HMB extract has anti‐inflammatory and antiallergic properties, is a component for AD treatment, and tends to develop topical products. Drug registration requires stability data. Results from drug stability testing affect not only the efficacy of the drug but also its safety. The aim of this study was to investigate stability through forced degradation and an accelerated study of extracts. Chemical content analysis and in vitro biological activities such as anti‐inflammatory and antiallergic activities determined the effects of all examined samples. Anti‐inflammatory and antiallergic effects were assessed by inhibiting nitric oxide synthesis in RAW 264.7 cells and β‐hexosaminidase release in RBL‐2H3 cells, respectively. High‐performance liquid chromatography (HPLC) assessed content indicators. Moisture and temperature hydrolysis had no significant differences in the chemical or biological properties of the HMB. However, the HMB demonstrated sensitivity to alkaline hydrolysis, showed low anti‐inflammatory activity, and decreased hydroxychavicol, eugenol, and α‐mangostin contents. The contents of the three compounds also decrease with acid hydrolysis. For the accelerated study, anti‐inflammatory and antiallergic effects and hydroxychavicol amount were not significantly different after 180 days at 40°C and 75% RH. Therefore, the contents of eugenol and α‐mangostin were changed. Eugenol in HMB decreased significantly from the 15th day until the 180th day of storage. In addition, α‐mangostin amounts in HMB decreased slightly on 180th day. Fortunately, reducing the two chemicals did not affect anti‐inflammatory or antiallergic effects. For stability, combination extract should be stored in a closed container in the refrigerator at a low temperature and protected from light, high temperature, oxygen, and pH. Further HMB development should avoid pH or oxidation processes or components.
- 24 October 2017
- Published by Georg Thieme Verlag KG
- Vol. 4 (S 01) , Tu-PO-83
Cytotoxic activity of medicinal plants selected from Euphorbiaceae family against Hepatocellular carcinoma cell
Euphorbiaceae is the large flowering plant families. A variety of Euphorbiaceae-based phytochemicals including alkaloids, flavonoids, saponins, tannins, phenols and essential oils, it would appear that their diverse medicinal properties. In this study we investigated the cytotoxic activity of the selected medicinal plants from Euphorbiaceae family against hepatocellular carcinoma cell line (HepG2) by using sulphorhodamine B (SRB) assay. The aqueous and ethanolic extract from Ricinus communis Linn, Jatropha multifida Linn, Euphorbia antiquorum Linn, Trigonostemon reidioides (Kurz) Craib and Bridelia ovata Decne. were tested for screen their cytotoxic activity against HepG2. The results found that only 3 ethanolic extracts with potent cytotoxic activity (IC50 < 50 µg/ml). The ethanolic extract of T. reidioides showed the highest cytotoxic activity against HepG2 which IC50 of 0.016 ± 0.002 µg/ml following by E. antiquorum 0.43 ± 0.02 µg/ml. And the ethanolic extract of J. multifida showed less cytotoxic activity against HepG2 which IC50 of 26.20 ± 1.15 µg/ml. In conclusion, this study obtained the potent natural source for anti-liver cancer from T. reidioides and E. antiquorum. It should be continuously isolate cytotoxic compounds from this plant.
- 24 October 2017
- Published by Georg Thieme Verlag KG
- Vol. 4 (S 01) , Tu-PO-83
Cytotoxic activity of medicinal plants selected from Euphorbiaceae family against Hepatocellular carcinoma cell
Euphorbiaceae is the large flowering plant families. A variety of Euphorbiaceae-based phytochemicals including alkaloids, flavonoids, saponins, tannins, phenols and essential oils, it would appear that their diverse medicinal properties. In this study we investigated the cytotoxic activity of the selected medicinal plants from Euphorbiaceae family against hepatocellular carcinoma cell line (HepG2) by using sulphorhodamine B (SRB) assay. The aqueous and ethanolic extract from Ricinus communis Linn, Jatropha multifida Linn, Euphorbia antiquorum Linn, Trigonostemon reidioides (Kurz) Craib and Bridelia ovata Decne. were tested for screen their cytotoxic activity against HepG2. The results found that only 3 ethanolic extracts with potent cytotoxic activity (IC50 < 50 µg/ml). The ethanolic extract of T. reidioides showed the highest cytotoxic activity against HepG2 which IC50 of 0.016 ± 0.002 µg/ml following by E. antiquorum 0.43 ± 0.02 µg/ml. And the ethanolic extract of J. multifida showed less cytotoxic activity against HepG2 which IC50 of 26.20 ± 1.15 µg/ml. In conclusion, this study obtained the potent natural source for anti-liver cancer from T. reidioides and E. antiquorum. It should be continuously isolate cytotoxic compounds from this plant.